Ahead of the 16th Laboratory Informatics Summit, Pharma IQ asked a set of experts to provide their insight into trends within the use of structured and unstructured data in the lab informatics world. Commentary is provided by Darryl Davies, Associate Director, Janssen.
Last summer, the Zika virus outbreak triggered a worldwide health alert. Today, pathogen is a discovery priority as there is still no treatment in existence to combat the disease
Despite the volume of deals dipping, pharma companies paid a lot more for mergers and acquisitions in 2016. The FT reports that the value of deals increased by almost double.
This eBook examines the hurdles faced in operating clinical trials when pharma firms are in the late stages of digitizing a TMF system and some documents are left in hard copy.
Limitations in compatibility between certain single use system devices for biomanufacturing is a challenge that has raged for quite some time. A number of experts discuss the latest on the matter and the solution that the biotech and biopharma market needs for this sticking point in the industry.
Ahead of the Cell and Gene Therapy Manufacturing conference, Pharma IQ examines the top 10 challenges that complicate the route to manufacturing commercial cell and gene products.
Anna Holefors, CEO of In vitro Plant-Tech considers the technologies and trends that could shake up the biomanufacturing space for medicines.
Pharma IQ explores the power behind medicine optimisation and the trends emerging in the pharma and healthcare market recently.
Single use systems provide numerous benefits to the process of biomanufacturing including the prospect of faster turnaround times for biotech and biopharma firms. Here Michael Eakins, Vice Chair of the USP Packaging... Read more
This heatmap scans the cell and gene manufacturing activity occurring across Europe on the road to commercializing these therapies.